Global Organ-on-Chips Market By Type (liver, heart, lungs and others); By Application (drug discovery, toxicology research and other applications); By end-user (Pharmaceutical and biotechnology companies, academic and research institutes and others) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030.
Product overview
Organ-on-chips is a glass slide coated with human cells configured to imitate a tissue such as a lung or heart. It is also called a multi-channel 3D microfluid cell culture chip which develops a narrow channel for blood and airflow in organs. It is an artificial organ that replicates activities, mechanics, and physiological responses of the organ system. It is the size of a AA battery that allows seeing the functionality of organs, their behavior and response at the molecular and cellular level.
Market highlights
Global Organ-on-a-Chip Market grew at USD XXX million in 2019 and is expected to grow at a CAGR of XX% in the forecasted period. An increase in animal testing, research funding, capital investments, new product launches, and a rise in technological investments is likely to increase the growth of the market.
Source: Fatpos Global
Global Organ-on-Chips Market: Segments
Global Organ-on-a-Chip Market can be segmented on the basis of type, application, end-user, and regions.
By organ type, it can be categorized into the liver, heart, lungs, and others. The liver segment shows significant growth due to the increased liver-related diseases along with the ability of on-chip hepatic tissues to maintain metabolism.
By application, it can be segmented into drug discovery, toxicology research, and other applications. Technological advancements and an increase in drug toxicity demand are reasons for the growth of the drug segment.
Global Organ-on-a-Chip Market by end-user is divided into Pharmaceutical and biotechnology companies, academic and research institutes, and others. Increasing research investment in the pharmaceutical sector across is likely to dominate the growth in the sector
The region segment can be further divided into five major types including North America, Latin America, Europe, APAC, and MENA.
Global Organ-on-Chips Market: Drivers and Restraints
High usage is expected to increase the market size
The growing usage of the organ-on-chips market for animal testing and in the healthcare sector and a rising number of alliances between the pharmaceutical firms and chips manufacturers are expected to increase market growth. Additionally, technological advancements and an increase in drug toxicity demand is also a driver in the market.
Technical issues and high costs will restrain the market growth
There are a lot of technical problems linked with organ-on-chips technology which acts as a restraint in the market along with the high cost as well as complexities in the organ-on-chip model. Restrictions in polydimethylsiloxane which is the most commonly used material for fabrications of the organ-on-chips market also acts as a hindrance in the growth of the market.
Global Organ-on-Chips Market: Regions
The region segment can be further divided into five major types including North America, Latin America, Europe, APAC, and MENA.
North America holds the largest share in the organ-on-chips market due to the increased support of the government in drug discovery research activities as well as the presence of world-class research institutes and pharmaceutical and biotechnology industries in the region. Though, the APAC region is expected to become the fastest-growing region due to the increase in disposable income of the people and increased government funding for medicines in research institutes as well as the growing investments in research and development.
Source: Fatpos Global
Global Organ-on-a-Chip Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Global Organ-on-Chips Market: Key players
Nortis
Business Strategy
Key Product offerings
Financial performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis
Organovo Holdings, Inc.
Hurel Corporation
Insphero AG
MIMETAS BV
Mimetas
Emulate
InSphero
Ascendance Bio
AxoSim
Global Organ-on-a-Chip Market report also contains analysis on:
Global Organ-on-Chips Market segments:-
By type :
Liver
Lungs
Heart
others
By application :
drug discovery
toxicology research
other applications
By end-user :
Pharmaceutical and biotechnology companies
academic and research institutes
others
Global Organ-on-Chips Market dynamics
Global Organ-on-Chips Market size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
FAQs on Global Organ-on-Chips Market
Which segment is anticipated to hold the largest market share?
At what CAGR is the market anticipated to grow between 2020 and 2030?
Who are the key players in Global Organ-on-Chips Market?
What could be the challenging factors for the growth of Global Organ-on-Chips Market?
What are the growth drivers for Global Organ-on-Chips Market?
Organ-on-chips is a glass slide coated with human cells configured to imitate a tissue such as a lung or heart. It is also called a multi-channel 3D microfluid cell culture chip which develops a narrow channel for blood and airflow in organs. It is an artificial organ that replicates activities, mechanics, and physiological responses of the organ system. It is the size of a AA battery that allows seeing the functionality of organs, their behavior and response at the molecular and cellular level.
Market highlights
Global Organ-on-a-Chip Market grew at USD XXX million in 2019 and is expected to grow at a CAGR of XX% in the forecasted period. An increase in animal testing, research funding, capital investments, new product launches, and a rise in technological investments is likely to increase the growth of the market.
Source: Fatpos Global
Global Organ-on-Chips Market: Segments
Global Organ-on-a-Chip Market can be segmented on the basis of type, application, end-user, and regions.
By organ type, it can be categorized into the liver, heart, lungs, and others. The liver segment shows significant growth due to the increased liver-related diseases along with the ability of on-chip hepatic tissues to maintain metabolism.
By application, it can be segmented into drug discovery, toxicology research, and other applications. Technological advancements and an increase in drug toxicity demand are reasons for the growth of the drug segment.
Global Organ-on-a-Chip Market by end-user is divided into Pharmaceutical and biotechnology companies, academic and research institutes, and others. Increasing research investment in the pharmaceutical sector across is likely to dominate the growth in the sector
The region segment can be further divided into five major types including North America, Latin America, Europe, APAC, and MENA.
Global Organ-on-Chips Market: Drivers and Restraints
High usage is expected to increase the market size
The growing usage of the organ-on-chips market for animal testing and in the healthcare sector and a rising number of alliances between the pharmaceutical firms and chips manufacturers are expected to increase market growth. Additionally, technological advancements and an increase in drug toxicity demand is also a driver in the market.
Technical issues and high costs will restrain the market growth
There are a lot of technical problems linked with organ-on-chips technology which acts as a restraint in the market along with the high cost as well as complexities in the organ-on-chip model. Restrictions in polydimethylsiloxane which is the most commonly used material for fabrications of the organ-on-chips market also acts as a hindrance in the growth of the market.
Global Organ-on-Chips Market: Regions
The region segment can be further divided into five major types including North America, Latin America, Europe, APAC, and MENA.
North America holds the largest share in the organ-on-chips market due to the increased support of the government in drug discovery research activities as well as the presence of world-class research institutes and pharmaceutical and biotechnology industries in the region. Though, the APAC region is expected to become the fastest-growing region due to the increase in disposable income of the people and increased government funding for medicines in research institutes as well as the growing investments in research and development.
Source: Fatpos Global
Global Organ-on-a-Chip Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Global Organ-on-Chips Market: Key players
Nortis
Business Strategy
Key Product offerings
Financial performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis
Organovo Holdings, Inc.
Hurel Corporation
Insphero AG
MIMETAS BV
Mimetas
Emulate
InSphero
Ascendance Bio
AxoSim
Global Organ-on-a-Chip Market report also contains analysis on:
Global Organ-on-Chips Market segments:-
By type :
Liver
Lungs
Heart
others
By application :
drug discovery
toxicology research
other applications
By end-user :
Pharmaceutical and biotechnology companies
academic and research institutes
others
Global Organ-on-Chips Market dynamics
Global Organ-on-Chips Market size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
FAQs on Global Organ-on-Chips Market
Which segment is anticipated to hold the largest market share?
At what CAGR is the market anticipated to grow between 2020 and 2030?
Who are the key players in Global Organ-on-Chips Market?
What could be the challenging factors for the growth of Global Organ-on-Chips Market?
What are the growth drivers for Global Organ-on-Chips Market?
1. EXECUTIVE SUMMARY
2. GLOBAL ORGAN-ON-CHIPS MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MARKET DYNAMICS
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. CORRELATION & REGRESSION ANALYSIS
6.1. Correlation Matrix
6.2. Regression Matrix
7. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
8. RISK ANALYSIS
8.1. Demand Risk Analysis
8.2. Supply Risk Analysis
9. GLOBAL ORGAN-ON-CHIPS MARKET ANALYSIS
9.1. Porters Five Forces
9.1.1. The threat of New Entrants
9.1.2. Bargaining Power of Suppliers
9.1.3. Threat of Substitutes
9.1.4. Rivalry
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. GLOBAL ORGAN-ON-CHIPS MARKET
10.1. Market Size & forecast, 2019A-2030F
10.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. GLOBAL ORGAN-ON-CHIPS MARKET: MARKET SEGMENTATION
11.1. By Regions
11.1.1. North America:(U.S. and Canada)
11.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
11.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
11.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
11.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.5. The Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
11.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.2. By Type: Market Share (2020-2030F)
11.2.1. Liver, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.2.2. Lungs, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.2.3. Heart, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.2.4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.3. By End User: Market Share (2020-2030F)
11.3.1. Pharmaceutical and biotechnology companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.3.2. Academic and research institutes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.3.3. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.4. By Biotechnology: Market Share (2020-2030F)
11.4.1. Public, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.4.2. Private, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.5. By Application: Market Share (2020-2030F)
11.5.1. Drug Discovery, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.5.2. Toxicology Research, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.5.3. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. COMPANY PROFILE
12.1. Nortis
12.1.1. Company Overview
12.1.2. Company Total Revenue (Financials)
12.1.3. Market Potential
12.1.4. Global Presence
12.1.5. Key Performance Indicators
12.1.6. SWOT Analysis
12.1.7. Product Launch
12.2. Organovo Holdings, Inc.
12.3. Hurel Corporation
12.4. Insphero AG
12.5. MIMETAS BV
12.6. Emulate
12.7. InSphero
12.8. Ascendance Bio
12.9. AxoSim
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. GLOBAL ORGAN-ON-CHIPS MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MARKET DYNAMICS
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. CORRELATION & REGRESSION ANALYSIS
6.1. Correlation Matrix
6.2. Regression Matrix
7. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
8. RISK ANALYSIS
8.1. Demand Risk Analysis
8.2. Supply Risk Analysis
9. GLOBAL ORGAN-ON-CHIPS MARKET ANALYSIS
9.1. Porters Five Forces
9.1.1. The threat of New Entrants
9.1.2. Bargaining Power of Suppliers
9.1.3. Threat of Substitutes
9.1.4. Rivalry
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. GLOBAL ORGAN-ON-CHIPS MARKET
10.1. Market Size & forecast, 2019A-2030F
10.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. GLOBAL ORGAN-ON-CHIPS MARKET: MARKET SEGMENTATION
11.1. By Regions
11.1.1. North America:(U.S. and Canada)
11.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
11.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
11.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
11.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.5. The Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
11.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.2. By Type: Market Share (2020-2030F)
11.2.1. Liver, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.2.2. Lungs, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.2.3. Heart, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.2.4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.3. By End User: Market Share (2020-2030F)
11.3.1. Pharmaceutical and biotechnology companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.3.2. Academic and research institutes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.3.3. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.4. By Biotechnology: Market Share (2020-2030F)
11.4.1. Public, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.4.2. Private, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.5. By Application: Market Share (2020-2030F)
11.5.1. Drug Discovery, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.5.2. Toxicology Research, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.5.3. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. COMPANY PROFILE
12.1. Nortis
12.1.1. Company Overview
12.1.2. Company Total Revenue (Financials)
12.1.3. Market Potential
12.1.4. Global Presence
12.1.5. Key Performance Indicators
12.1.6. SWOT Analysis
12.1.7. Product Launch
12.2. Organovo Holdings, Inc.
12.3. Hurel Corporation
12.4. Insphero AG
12.5. MIMETAS BV
12.6. Emulate
12.7. InSphero
12.8. Ascendance Bio
12.9. AxoSim
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
